Recent Updates
Recently added Catalysts
HCM Neutral Sentiment Score: 60/100

Blocklisting Six Monthly Return Hong Kong, Shanghai, & Florham Park, NJ - Friday

Key Takeaway: HUTCHMED (China) Limited announced its blocklisting six monthly return for the period from December 29, 2023, to June 28, 2024. The 2015 HUTCHMED Share Option Scheme continues to have a remaining balance of 46,743,768 ordinary shares not yet issued. During the reporting period, 103,450 shares were allotted under the scheme. The total number of ordinary shares issued at the end of the period stands at 871,359,720.

Market Sentiment Analysis

Full Press Release Details

Blocklisting Six Monthly Return
Hong Kong, Shanghai, & Florham Park, NJ - Friday, June 28, 2024: HUTCHMED (China) Limited ("HUTCHMED" or the "Company") (Nasdaq/AIM: HCM; HKEX: 13) announces the following blocklisting six monthly return:
1. Name of applicant: HUTCHMED (China) Limited
2. Name of scheme: Share Option Scheme conditionally adopted by HUTCHMED in 2015 ("2015 HUTCHMED Share Option Scheme")
3. Period of return: From December 29, 2023 to June 28, 2024
4. Balance under scheme from previous return: 2015 HUTCHMED Share Option Scheme: 46,847,218 ordinary shares of US$0.1 each
5. The amount by which the block scheme has been increased, if the scheme has been increased since the date of the last return: 2015 HUTCHMED Share Option Scheme: Nil
6. Number of securities issued/allotted under scheme during period: 2015 HUTCHMED Share Option Scheme: 103,450
7. Balance under scheme not yet issued/allotted at end of the period: 2015 HUTCHMED Share Option Scheme: 46,743,768 ordinary shares of US$0.1 each
8. Number and class of securities originally listed and the date of admission: 25,198,880 ordinary shares of US$0.1 each admitted on June 17, 2019 ( to replace the Company's previous block admission schemes following the Company's share subdivision which took effect on May 30, 2019)
9. Total number of securities in issue at the end of the period: 871,359,720 ordinary shares of US$0.1 each
Name of contact: Weiguo Su
Address of contact: Level 18, The Metropolis Tower, 10 Metropolis Drive, Hung Hom, Kowloon, Hong Kong
Telephone number of contact: +852 2121 8200
Investor Enquiries +852 2121 8200 / ir@hutch-med.com
Media Enquiries
Ben Atwell / Alex Shaw, FTI Consulting +44 20 3727 1030 / +44 7771 913 902 (Mobile) / +44 7779 545 055 (Mobile) / HUTCHMED@fticonsulting.com
Zhou Yi, Brunswick +852 9783 6894 (Mobile) / HUTCHMED@brunswickgroup.com
Nominated Advisor
Atholl Tweedie / Freddy Crossley / Rupert Dearden, Panmure Gordon +44 (20) 7886 2500

Frequently Asked Questions

What is the 2015 HUTCHMED Share Option Scheme?

The 2015 HUTCHMED Share Option Scheme was conditionally adopted by HUTCHMED in 2015.

How many shares remain under the 2015 scheme?

At the end of the period, 46,743,768 ordinary shares remain unissued.

How many shares were allotted in the recent period?

During the period, 103,450 shares were issued under the scheme.

What was the total share count at the period's end?

The total number of shares outstanding at the end was 871,359,720.

Who can I contact for investor inquiries?

Investor inquiries can be directed to Weiguo Su at +852 2121 8200.

Last updated: Jun 28, 2024